Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition Tsunehisa NomuraMasaaki KawaiShigehira Saji Special Article Open access 08 April 2023 Pages: 519 - 530
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis Jun WatanabeYuki KataokaNaohiro Sata Review Article 14 April 2023 Pages: 531 - 540
Validity of computed mean compressed fibroglandular tissue thickness and breast composition for stratification of masking risk in Japanese women Mikinao OiwaNamiko SudaTokiko Endo Original Article 15 March 2023 Pages: 541 - 551
Centrally located breast carcinomas treated with central quadrantectomy and immediate nipple–areola reconstruction: a cohort study Hernanz FernandoGonzález NoeliaMuñoz Pedro ORIGINAL ARTICLE 03 March 2023 Pages: 552 - 558
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study Maria Donatella MarinielloMatteo GhilliManuela Roncella Original Article 28 March 2023 Pages: 559 - 569
Development and implementation of a decision aid for post-mastectomy breast reconstruction for Japanese women with breast cancer: a field-testing study Yoshihiro SowaNaoki InafukuNaoki Morimoto Original Article 18 March 2023 Pages: 570 - 576
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study Mari KikuchiNaoya GomiTakashi Terauchi Original Article 10 March 2023 Pages: 577 - 583
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients Masayuki NagahashiYiWei LingToshifumi Wakai Original Article 17 March 2023 Pages: 584 - 595
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial Hideko YamauchiMasakazu ToiAndrew Tutt Original Article Open access 01 April 2023 Pages: 596 - 605
Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial Hideko YamauchiMasakazu ToiAndrew Tutt Correction Open access 12 May 2023 Pages: 606 - 606
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry Shozo OhsumiKenichi WatanabeHirofumi Mukai Original Article Open access 17 April 2023 Pages: 607 - 616
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study Murat AkyolAlper TuğralYeşim Bakar Original Article 23 March 2023 Pages: 617 - 626
Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare Rashmi PathakMacall LeslieTakemi Tanaka Original Article Open access 03 May 2023 Pages: 627 - 636
High-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imaging Shun KawaguchiKeiichi KinowakiHidetaka Kawabata Original Article 05 April 2023 Pages: 637 - 646
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis Yile JiaoXinyi GuoQing Lv Original Article 27 April 2023 Pages: 647 - 656
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan K. NozawaM. TeradaJunji Tsurutani Original Article Open access 22 May 2023 Pages: 657 - 665
Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation Leilei LiWenhui YangGuanghui Wang Original Article Open access 13 May 2023 Pages: 666 - 684
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees Kazumi JinboTakaaki FujitaYuichi Yamamoto Rapid Communication 14 March 2023 Pages: 685 - 688
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region Nobumoto TomiokaKanako C. HatanakaMasato Takahashi Correction Open access 27 April 2023 Pages: 689 - 690